NEOVACS SA (UK) Analysis


EUR 0.19  0.005  2.70%   

The big decline in price over the last few months for NEOVACS SA NEOVACS could raise concerns from stakeholders as the firm is trading at a share price of 0.19 on very low momentum in volume. The company executives failed to add value to investors and position the firm supply of money to exploit market volatility in July. However, diversifying your holdings with NEOVACS SA or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.5. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the NEOVACS SA NEOVACS partners.
Please continue to Trending Equities.
The NEOVACS SA stock analysis report makes it easy to digest most publicly released information about NEOVACS SA and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. NEOVACS Stock analysis module also helps to analyze the NEOVACS SA price relationship with some important fundamental indicators such as market cap and management efficiency.

NEOVACS Stock Analysis Notes

The company recorded a loss per share of 0.0. NEOVACS SA NEOVACS had not issued any dividends in recent years. Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. Neovacs S.A. was founded in 1993 and is based in Paris, France. NEOVACS SA is traded on London Stock Exchange in UK. For more info on NEOVACS SA NEOVACS please contact the company at 33 1 53 10 93 00 or go to

NEOVACS SA NEOVACS Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. NEOVACS SA's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding NEOVACS SA NEOVACS or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
NEOVACS SA NEOVACS is not yet fully synchronised with the market data
NEOVACS SA NEOVACS generated a negative expected return over the last 90 days
NEOVACS SA NEOVACS has high historical volatility and very poor performance
NEOVACS SA NEOVACS has some characteristics of a very speculative penny stock
NEOVACS SA NEOVACS has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 90.52 K. Net Loss for the year was (2.88 M) with loss before overhead, payroll, taxes, and interest of (1.69 M).
NEOVACS SA NEOVACS has accumulated about 35.78 M in cash with (6.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 100.49, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Management Efficiency

NEOVACS SA NEOVACS has return on total asset (ROA) of (15.96) % which means that it has lost $15.96 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (17.85) %, meaning that it generated substantial loss on money invested by shareholders. NEOVACS SA management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

NEOVACS SA Technical and Predictive Indicators

About NEOVACS Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how NEOVACS SA stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NEOVACS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as NEOVACS SA. By using and applying NEOVACS Stock analysis, traders can create a robust methodology for identifying NEOVACS entry and exit points for their positions.
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. Neovacs S.A. was founded in 1993 and is based in Paris, France. NEOVACS SA is traded on London Stock Exchange in UK.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding NEOVACS SA to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run ETF Directory Now


ETF Directory

Find actively traded Exchange Traded Funds (ETF) from around the world
All  Next Launch Module
Please continue to Trending Equities. Note that the NEOVACS SA NEOVACS information on this page should be used as a complementary analysis to other NEOVACS SA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Tools for NEOVACS Stock

When running NEOVACS SA NEOVACS price analysis, check to measure NEOVACS SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NEOVACS SA is operating at the current time. Most of NEOVACS SA's value examination focuses on studying past and present price action to predict the probability of NEOVACS SA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move NEOVACS SA's price. Additionally, you may evaluate how the addition of NEOVACS SA to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments